Intralesional Abciximab and Thrombus Aspiration in Patients With Large Anterior Myocardial Infarction: One-Year Results From the INFUSE-AMI Trial [ST-Segment-Elevation Myocardial Infarction]
Conclusions—
Intralesional abciximab and thrombus aspiration may have long-term benefits in patients with anterior ST-segment–elevation myocardial infarction presenting early after symptom onset and undergoing primary percutaneous coronary intervention with bivalirudin anticoagulation.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00976521.
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Stone, G. W., Witzenbichler, B., Godlewski, J., Dambrink, J.-H. E., Ochala, A., Chowdhary, S., El-Omar, M., Neunteufl, T., Metzger, D. C., Dizon, J. M., Wolff, S. D., Brener, S. J., Mehran, R., Maehara, A., Gibson, C. M. Tags: ST-Segment-Elevation Myocardial Infarction Source Type: research
More News: Abciximab | Angiomax | Angioplasty | Cardiology | Cardiovascular | Clinical Trials | Coronary Angioplasty | Heart | Heart Attack | Heart Failure | Percutaneous Coronary Intervention | Thrombosis